ACADIA Pharmaceuticals Inc.
ACAD
$29.68
$0.290.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.50M | 3.64M | 273.57M | 71.78M | 26.67M |
| Total Depreciation and Amortization | 3.16M | 2.99M | 2.92M | 2.95M | 2.94M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.66M | 14.15M | -237.31M | 12.08M | 12.80M |
| Change in Net Operating Assets | 39.46M | 13.20M | -87.91M | -12.52M | 21.55M |
| Cash from Operations | 100.78M | 33.98M | -48.73M | 74.29M | 63.96M |
| Capital Expenditure | -5.09M | -5.21M | -4.01M | -388.00K | -297.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.44M | 71.49M | -51.86M | -78.96M | -43.00M |
| Cash from Investing | -8.53M | 66.28M | -55.87M | -79.35M | -43.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.49M | 4.23M | 22.67M | 9.42M | 15.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.49M | 4.23M | 22.67M | 9.42M | 15.96M |
| Foreign Exchange rate Adjustments | 27.00K | 25.00K | 7.00K | 0.00 | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.77M | 104.52M | -81.93M | 4.36M | 36.64M |